美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Inhibitor Therapeutics Inc.

0.0770

-0.0065-7.78%

成交量：2.26萬

成交額：1,742.09

市值：1,328.82萬

市盈率：- -

高：0.0785

開：0.0785

低：0.0770

收：0.0835

52周最高：0.1238

52周最低：0.0351

股本：1.73億

流通股本：3,637.86萬

量比：0.82

換手率：0.06%

股息：- -

股息率：- -

淨資產收益率：-952.30%

總資產收益率：-72.57%

市淨率：-6.72

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

Inhibitor Therapeutics公布伊曲康唑治療戈林綜合徵項目的臨床、製劑及知識產權進展

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/INTI/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"INTI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"INTI\",,,,,undefined,":{"symbol":"INTI","market":"US","secType":"STK","nameCN":"Inhibitor Therapeutics Inc.","latestPrice":0.077,"timestamp":1780689600000,"preClose":0.0835,"halted":0,"volume":22570,"delay":15,"changeRate":-0.07784431137724557,"floatShares":36378595,"shares":172573545,"eps":0,"marketStatus":"已收盤","change":-0.0065,"latestTime":"06-05 16:00:00 EDT 延時","open":0.0785,"high":0.0785,"low":0.077,"amount":1742.09,"amplitude":0.017964,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1780905600000},"marketStatusCode":5,"adr":0,"exchange":"OTCQB","adjPreClose":0.0835,"volumeRatio":0.81966},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"INTI\",,,,,undefined,":{"symbol":"INTI","floatShares":36378595,"roa":"-72.57%","roe":"-952.30%","lyrEps":0,"volumeRatio":0.81966,"shares":172573545,"dividePrice":0,"high":0.0785,"amplitude":0.017964,"preClose":0.0835,"low":0.077,"week52Low":0.0351,"pbRate":"-6.72","week52High":0.12375,"institutionHeld":0,"latestPrice":0.077,"eps":0,"divideRate":0,"volume":22570,"delay":15,"open":0.0785,"prevYearClose":0.045,"prevWeekClose":0.085,"prevMonthClose":0.085,"prevQuarterClose":0.1087,"fiveDayClose":0.085,"twentyDayClose":0.09,"sixtyDayClose":0.088},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/INTI\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-11-12","symbol":"INTI","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤前","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2024-08-06","symbol":"INTI","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤前","type":"earning","dateTimestamp":1722916800000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2024-05-13","symbol":"INTI","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤前","type":"earning","dateTimestamp":1715572800000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2024-03-29","symbol":"INTI","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1711684800000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2023-11-13","symbol":"INTI","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤前","type":"earning","dateTimestamp":1699851600000,"reportTimeType":"pre","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"INTI\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"INTI\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"INTI\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1160374830","title":"Inhibitor Therapeutics公布伊曲康唑治療戈林綜合徵項目的臨床、製劑及知識產權進展","url":"https://stock-news.laohu8.com/highlight/detail?id=1160374830","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160374830?lang=zh_tw&edition=fundamental","pubTime":"2026-04-01 03:45","pubTimestamp":1774986311,"startTime":"0","endTime":"0","summary":"Inhibitor Therapeutics Inc. (简称INTI) 近日宣布，针对其用于治疗戈林综合征的伊曲康唑项目，已取得一系列重要进展。此次更新主要涵盖临床研究、制剂开发及知识产权保护三大关键领域，标志着该项目在研发进程中迈出了坚实的一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","INTI"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":1,"code":"91000000","status":"200"}]}}